Pam Menaker Writes ABA Litigation News Article on Fosamax Case | Clifford Law Offices PC
Aviation Attorney Robert Clifford Weighs In on Air India Flight AI-171 Crash Bob Clifford shares insights into the 2025 Air India aviation disaster and potential implications for global aviation safety.
Free Consultation (312) 899-9090
Select Language

    Pam Menaker Writes ABA Litigation News Article on Fosamax Case

    Contact Us
    Posted on October 22, 2014 To

    Pamela Sakowicz Menaker, Communications Partner at Clifford Law Offices, recently wrote an article that was published by the American Bar Association Litigation News on a recent court case that held that a defendant cannot be held liable in a products liability multi-district action if the company is compliant with Food and Drug Administration (FDA) rules. In a failure-to-warn complaint alleging the drug company, Merck, was negligent in its labeling following an injury to a patient, a New Jersey district court held the plaintiff’s action failed because the original label was complaint with FDA standards. To read more about this interesting case, please read “No Failure-to-Warn if FDA Compliant